Decibel Therapeutics Inc DBTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/28/22 EDT
3.40quote price arrow down-0.12 (-3.41%)
Volume
59,284
52 week range
1.83 - 8.66
Loading...
  • Open3.44
  • Day High3.59
  • Day Low3.38
  • Prev Close3.40
  • 52 Week High8.66
  • 52 Week High Date11/04/21
  • 52 Week Low1.83
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap84.86M
  • Shares Out24.96M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.88

KEY STATS

  • Open3.44
  • Day High3.59
  • Day Low3.38
  • Prev Close3.40
  • 52 Week High8.66
  • 52 Week High Date11/04/21
  • 52 Week Low1.83
  • 52 Week Low Date05/09/22
  • Market Cap84.86M
  • Shares Out24.96M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.88

RATIOS/PROFITABILITY

  • EPS (TTM)-2.42
  • P/E (TTM)-1.40
  • Fwd P/E (NTM)-1.26
  • EBITDA (TTM)-57.346M
  • ROE (TTM)-42.92%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.11%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Decibel Therapeutics Inc

 

Profile

MORE
Decibel Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing transformative treatments for hearing and balance disorder. It is focused on restoring and improving hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. The Company has built a platform that integrates single-cell genomics and bioinformatics analyses, precision gene...
William Carson M.D.
Independent Chairman of the Board
Laurence Reid Ph.D.
President, Chief Executive Officer, Director
Elisabeth Leiderman M.D.
Chief Financial Officer, Head - Corporate Development, Principal Accounting Officer
Address
1325 Boylston Street, Suite 500
Boston, MA
02215
United States

Top Peers

SYMBOLLASTCHG%CHG
RZLT
Rezolute Inc
2.71-0.09-3.21%
ADVM
Adverum Biotechnologies Inc
0.9487-0.0194-2.0039%
CADL
Candel Therapeutics Inc
3.20+0.03+0.95%
GALT
Galectin Therapeutics Inc
1.65-0.03-1.79%
IFRX
InflaRx NV
2.60+0.11+4.42%